Disseminated Mycobacterium Avium Infection in a Child with Complete Interferon-γ Receptor 1 Deficiency due to Compound Heterozygosis of IFNGR1 for a Subpolymorphic Copy Number Variation and a Novel Splice-Site Variant

Abstract

Complete interferon-γ receptor 1 deficiency is a monogenic primary immunodeficiency caused by IFNGR1 germline defects, with autosomal dominant or recessive inheritance, which results in invasive mycobacterial diseases with varying degrees of severity. Most of the autosomal recessive IFNGR1 mutations are homozygous loss-of-function single-nucleotide variants, whereas large genomic deletions and compound heterozygosity have been very rarely reported. Herein we describe the clinical presentation, diagnosis, and successful treatment with hematopoietic stem cell transplantation of a child with disseminated Mycobacterium avium infection due to compound heterozygosity for a subpolymorphic copy number variation and a novel splice-site variant.

Keywords

IFNGR1 gene - compound heterozygosity - copy number variation

• References

• 1 Bustamante J, Boisson-Dupuis S, Abel L, Casanova JL. Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity. Semin Immunol 2014; 26 (06) 454-470
• 2 Filipe-Santos O, Bustamante J, Chapgier A. , et al. Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features. Semin Immunol 2006; 18 (06) 347-361
• 3 Vankayalapati R, Wizel B, Samten B. , et al. Cytokine profiles in immunocompetent persons infected with Mycobacterium avium complex. J Infect Dis 2001; 183 (03) 478-484
• 4 Jouanguy E, Altare F, Lamhamedi S. , et al. Interferon-γ-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. N Engl J Med 1996; 335 (26) 1956-1961
• 5 Newport MJ, Huxley CM, Huston S. , et al. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med 1996; 335 (26) 1941-1949
• 6 Rosain J, Kong XF, Martinez-Barricarte R. , et al. Mendelian susceptibility to mycobacterial disease: 2014-2018 update. Immunol Cell Biol 2019; 97 (04) 360-367
• 7 The NCBI Gene Database; National Library of Medicine (US). IFNGR1 Interferon Gamma Receptor 1, Gene ID: 3459. Available at: https://www.ncbi.nlm.nih.gov/gene/3459 . Accessed October 14, 2016
• 8 van de Vosse E, van Dissel JT. IFN-γR1 defects: Mutation update and description of the IFNGR1 variation database. Hum Mutat 2017; 38 (10) 1286-1296
• 9 Shabani M, Aleyasin S, Kashef S. , et al. A novel recessive mutation of interferon gamma receptor 1 in a patient with Mycobacterium tuberculosis in bone marrow aspirate. J Clin Immunol 2019; 39 (02) 127-130
• 10 Dorman SE, Picard C, Lammas D. , et al. Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies. Lancet 2004; 364 (9451): 2113-2121
• 11 Olbrich P, Martínez-Saavedra MT, Perez-Hurtado JM. , et al. Diagnostic and therapeutic challenges in a child with complete interferon-γ receptor 1 deficiency. Pediatr Blood Cancer 2015; 62 (11) 2036-2039
• 12 Wu UI, Holland SM. Host susceptibility to non-tuberculous mycobacterial infections. Lancet Infect Dis 2015; 15 (08) 968-980
• 13 Rosenzweig SD, Holland SM. Defects in the interferon-gamma and interleukin-12 pathways. Immunol Rev 2005; 203: 38-47
• 14 Fieschi C, Dupuis S, Picard C, Smith CI, Holland SM, Casanova JL. High levels of interferon gamma in the plasma of children with complete interferon gamma receptor deficiency. Pediatrics 2001; 107 (04) E48
• 15 Bax HI, Freeman AF, Anderson VL. , et al. B-cell lymphoma in a patient with complete interferon gamma receptor 1 deficiency. J Clin Immunol 2013; 33 (06) 1062-1066
• 16 Camcioglu Y, Picard C, Lacoste V. , et al. HHV-8-associated Kaposi sarcoma in a child with IFNgammaR1 deficiency. J Pediatr 2004; 144 (04) 519-523
• 17 Taramasso L, Boisson-Dupuis S, Garrè ML. , et al. Pineal germinoma in a child with interferon-γ receptor 1 deficiency. case report and literature review. J Clin Immunol 2014; 34 (08) 922-927
• 18 Hetzel M, Mucci A, Blank P. , et al. Hematopoietic stem cell gene therapy for IFNγR1 deficiency protects mice from mycobacterial infections. Blood 2018; 131 (05) 533-545
• 19 Rottman M, Soudais C, Vogt G. , et al. IFN-gamma mediates the rejection of haematopoietic stem cells in IFN-gammaR1-deficient hosts. PLoS Med 2008; 5 (01) e26
• 20 Delisle JS, Gaboury L, Bélanger MP, Tassé E, Yagita H, Perreault C. Graft-versus-host disease causes failure of donor hematopoiesis and lymphopoiesis in interferon-gamma receptor-deficient hosts. Blood 2008; 112 (05) 2111-2119
• 21 de Bruin AM, Voermans C, Nolte MA. Impact of interferon-γ on hematopoiesis. Blood 2014; 124 (16) 2479-2486
• 22 Reuter U, Roesler J, Thiede C. , et al. Correction of complete interferon-γ receptor 1 deficiency by bone marrow transplantation. Blood 2002; 100 (12) 4234-4235
• 23 Roesler J, Horwitz ME, Picard C. , et al. Hematopoietic stem cell transplantation for complete IFN-gamma receptor 1 deficiency: a multi-institutional survey. J Pediatr 2004; 145 (06) 806-812
• 24 Chantrain CF, Bruwier A, Brichard B. , et al. Successful hematopoietic stem cell transplantation in a child with active disseminated Mycobacterium fortuitum infection and interferon-γ receptor 1 deficiency. Bone Marrow Transplant 2006; 38 (01) 75-76
• 25 Moilanen P, Korppi M, Hovi L. , et al. Successful hematopoietic stem cell transplantation from an unrelated donor in a child with interferon gamma receptor deficiency. Pediatr Infect Dis J 2009; 28 (07) 658-660
• 26 de Vor IC, van der Meulen PM, Bekker V. , et al. Deletion of the entire interferon-γ receptor 1 gene causing complete deficiency in three related patients. J Clin Immunol 2016; 36 (03) 195-203
• 27 Yang Y, Muzny DM, Xia F. , et al. Molecular findings among patients referred for clinical whole-exome sequencing. JAMA 2014; 312 (18) 1870-1879
• 28 Jinnohara T, Kanaya T, Hase K. , et al. IL-22BP dictates characteristics of Peyer's patch follicle-associated epithelium for antigen uptake. J Exp Med 2017; 214 (06) 1607-1618
• 29 Andoh A, Zhang Z, Inatomi O. , et al. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology 2005; 129 (03) 969-984
• 30 Martin JC, Bériou G, Heslan M. , et al. IL-22BP is produced by eosinophils in human gut and blocks IL-22 protective actions during colitis. Mucosal Immunol 2016; 9 (02) 539-549
• 31 Bracaglia C, Prencipe G, Insalaco A. , et al. Emapalumab, an anti-interferon gamma monoclonal antibody in two patients with NLRC4-related disease and severe Hemophagocytic Lymphohistiocytosis (HLH) [abstract]. Arthritis Rheumatol 2018 70. (10). Available at: https://acrabstracts.org/abstract/emapalumab-an-anti-interferon-gamma-monoclonal-antibody-in-two-patients-with-nlrc4-related-disease-and-severe-hemophagocytic-lymphohistiocytosis-hlh/ . Accessed October 31, 2019